News

LARC use leads to dramatic drop in teen pregnancies


 

AT THE NASPAG ANNUAL MEETING

Dr. Madden disclosed that she receives honoraria for serving on an advisory board for Bayer Healthcare Pharmaceuticals and that she receives research funding from Merck.

dbrunk@frontlinemedcom.com

Pages

Recommended Reading

Two doses of HPV vaccine may be as effective as three
MDedge ObGyn
No or mild developmental disability in 73% of extremely preterm
MDedge ObGyn
Plan B One-Step now OTC for women 15-16 years old
MDedge ObGyn
Feds appeal ruling that makes Plan B available to all ages
MDedge ObGyn
Work-up, treatment of adolescent PCOS varies by specialty
MDedge ObGyn
LARCs appear safe in adolescents with CVD
MDedge ObGyn
Centering pregnancy program found to benefit adolescents
MDedge ObGyn
Establish confidentiality before discussing LARCs with teens
MDedge ObGyn
Most ovarian cysts in adolescents resolve
MDedge ObGyn
Feds push to restrict Plan B sales to young teens
MDedge ObGyn